- Price is above Fair Value, showing premium demand versus the model.
PRE
NASDAQ
Week ended 07 Aug 2026
Weekly Investor Report
Prenetics Global Ltd · Healthcare · Diagnostics & Research
Latest close
18.26 USD
-2.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -1.6% below the Trend Line and sits at 67.4% of its 52-week range. The latest completed week returned -2.0%, after a 2.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 58/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 29d.
Setup score
36
out of 100
Latest Close
18.26 USD
7 Aug 2026
1W Return
-2.0%
latest completed week
4W Return
2.2%
short-term follow-through
12W Return
17.0%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 40.95% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.0%
Latest completed week; four-week move 2.2%.
Indicator stack
49/52
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.95%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Volatility
58/100 conviction; expected move 22.1%.
News sentiment
52/100
32 relevant articles in the latest sentiment read.
Event risk
29d
Next report is scheduled for 11 Sep 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -1.6% below the Trend Line and sits at 67.4% of its 52-week range. The latest completed week returned -2.0%, after a 2.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5212-week average 0.50
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.52Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers77 reversal markers
No recent accumulation markers. 7 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.2% over four weeks, 17.0% over 12 weeks, and 146.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.18Latest activity-pressure read.
Pressure change69.6%Four-week change in activity pressure.
Leadership-0.86Latest relative-leadership reading.
RS change-297.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 85%
Model confidence 79%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength33/100Blend of value, momentum, and quality. Underlying universe rank 68; rank 1 is best.
Value28/100Relative valuation strength. Underlying universe rank 73; rank 1 is best.
Quality16/100Profitability and accounting quality. Underlying universe rank 85; rank 1 is best.
Momentum95/100Medium-term price momentum. Underlying universe rank 6; rank 1 is best.
Growth90/100Revenue and earnings growth. Underlying universe rank 11; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 2.7x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -8.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 58.3% Gross profit retained from each unit of revenue.
- Operating margin
- -47.7% Operating profit retained from revenue.
- Free-cash-flow margin
- -19.0% Free cash flow generated from revenue.
- Return on invested capital
- -62.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 227.8% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.0% Cash dividends relative to market value.
- Buyback yield
- -12.9% Net share repurchases relative to market value.
- Shareholder yield
- -12.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningVolatility
PRE shows volatility options pressure with a 58/100 conviction score, put-call volume ratio of 0.10, expected move of 22.1%, and Sharemaestro trend signal inactive.
Conviction58/100
Expected move22.1%
Put/call volume0.10
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 32 relevant articles.
12 positive · 16 neutral · 4 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings29dNext report is scheduled for 11 Sep 2026; event risk rises as the date approaches.
Options expected move22.1%Nearest-chain priced movement where available.
52-week drawdown-22.7%Distance below the 52-week high.
13-week volatility9.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+25.8%Week of 29 May.
Worst week-22.4%Week of 20 Feb.
Latest week-2.0%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks0
Modest losses4
Sharp losses10
Recent vol9.1%13-week weekly-return volatility.
Base vol9.7%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew8.9% / -6.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average2.6%
Trend breadth54.0%
Trend54.0%active weekly trend signals
MD77.0%positive activity pressure
RS44.0%positive relative leadership
Four-week leaders
IndustryUS Diagnostics & Research
4-week rank28 / 45
Group average6.0%
Trend breadth55.6%
Trend55.6%active weekly trend signals
MD80.0%positive activity pressure
RS42.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape33/100
Trend, activity pressure, participation, and risk combine to a 33/100 tape read.
Indicator analysis45/100Latest 12-week confirmation: trend 7/12, activity pressure 3/12, relative leadership 10/12.
Activity pressure 0.52; 7 reversal markers Next-Week ExpectancyNegative 40.95%Next-week expectancy is negative with a 40.95% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors40/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 88; Small Cap Core rank 77 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options37/100PRE shows volatility options pressure with a 58/100 conviction score, put-call volume ratio of 0.10, expected move of 22.1%, and Sharemaestro trend signal inactive.
Volatility · Volatility expansion watch · Expected move 22.1% Sentiment52/100Weighted news tone is neutral across 32 relevant articles.
Prenetics (Nasdaq: PRE) files F-1 to register 2.36M warrant shares for resale Insiders50/100No recent insider transaction evidence is stored.
Earnings29dNext report is scheduled for 11 Sep 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 18.26 USD | -2.0% | 18.56 USD | 9.14 USD | -0.18 | -0.86 | 512.5K | Off |
| 31 Jul 2026 | 18.64 USD | -0.5% | 18.47 USD | 9.09 USD | -0.25 | 7.35 | 437.5K | Off |
| 24 Jul 2026 | 18.74 USD | 2.5% | 18.37 USD | 9.04 USD | -0.39 | 9.57 | 1.4M | Off |
| 17 Jul 2026 | 18.29 USD | 2.4% | 18.31 USD | 8.99 USD | -0.50 | 6.31 | 2.5M | Off |
| 10 Jul 2026 | 17.86 USD | 5.5% | 18.29 USD | 8.95 USD | -0.60 | 0.44 | 660.6K | On |
| 3 Jul 2026 | 16.93 USD | -10.1% | 18.18 USD | 8.92 USD | -0.26 | -2.28 | 335.3K | On |
| 26 Jun 2026 | 18.83 USD | -8.1% | 18.09 USD | 8.90 USD | 0.05 | 10.44 | 611.7K | On |
| 19 Jun 2026 | 20.50 USD | -5.2% | 17.94 USD | 8.86 USD | 0.32 | 15.85 | 537.3K | On |
| 12 Jun 2026 | 21.63 USD | 8.9% | 17.68 USD | 8.82 USD | 0.17 | 26.59 | 1.6M | On |
| 5 Jun 2026 | 19.86 USD | -5.9% | 17.37 USD | 8.77 USD | -0.21 | 20.54 | 1.4M | On |
| 29 May 2026 | 21.10 USD | 25.8% | 17.12 USD | 8.72 USD | -0.50 | 23.56 | 1.6M | On |
| 22 May 2026 | 16.77 USD | 7.4% | 16.91 USD | 8.67 USD | -0.86 | 1.94 | 1.2M | Off |
| 15 May 2026 | 15.61 USD | -3.4% | 16.91 USD | 8.65 USD | -0.88 | -3.71 | 1.3M | Off |
| 8 May 2026 | 16.16 USD | -5.1% | 16.89 USD | 8.64 USD | -0.88 | 0.19 | 1.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.